| Catalog Number |
000000000002000684 |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
|
| Health Effect - Clinical Codes |
Thrombosis/Thrombus (4440); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/21/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
A4 is unknown.The impella device was not received from the customer, therefore, investigation of the device was not possible.Should the device or any new information be received, a supplemental mdr will be filed.
|
| |
|
Event or Problem Description
|
|
An intra aortic balloon pump (iabp) was exchanged for an impella cp10 with the 14fr low profile sheath via the right femoral artery in a 64 year old female patient for protected percutaneous intervention.The patient¿s comorbidities were unknown.The patient¿s clinical state prior to initiation of support was identified as scai shock stage d being supported by an iabp.The patient went to the icu on support with the 14 fr low profile sheath in place as instructed in the ifu.Post procedure it was noted that the impella insertion site was oozing.It is important to appreciate the risk of utilizing the same arteriotomy when exchanging the iabp for the impella.The physician voiced that they felt the initial stick for iabp was high which was contributing to the oozing.Standard troubleshooting and redressing the site resolved the ooze.After approximately 24 hours of support the patient was taken back to the cath lab for removal at which time the access site was flat and dry.Upon removal of the device there were noted concerns of thrombus but no documented thrombus related adverse event to the patient.While on support the device functioned within expected flow range p-6 2.7l/min.Percutaneous coronary intervention.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected information has been provided in d1, d2, d4 and h11.This supplemental report is being submitted to correct the identification of the suspected device.Upon further review of the reported event, the suspected device has been corrected from the pump to the introducer sheath.The pump is not considered to be the suspected medical device for this event.All continued reporting, evaluation, and follow-up will be performed under manufacturer report number 1220648-2026-06197, which is associated with the introducer sheath.
|
| |
|
Additional Manufacturer Narrative
|
|
B5 updated with additional information receive from the clinical site.
|
| |
|
Event or Problem Description
|
|
During pump removal, sheath sidearm aspirated, got stuck at 2/3cc changed port, pulled 20cc, no clot (but clot caught between sidearm and connector).Removed through sheath.The physician decided not to do planned angio due to thrombus concern.At sheath removal, sheath sidearm aspirated and clot found.Aspirated again, smaller clot found, but third aspiration was clear.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was received stating that the patient's dressing was changed in the icu and was dry the following morning.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated information: b3.Event date updated.B5.Clinical narrative updated.D4.Catalog number corrected.H6.Clinical code changed to e2403.H6.Impact code changed to f2601.H6.Med dev prob code changed to a25.
|
| |
|
Event or Problem Description
|
|
Clinical rationale: (updated 2026-3-30).An intra aortic balloon pump (iabp) was exchanged for an impella cp10 with the 14fr low profile sheath via the right femoral artery in a 64 year old female patient for protected percutaneous intervention.The patient¿s comorbidities were unknown.The patient¿s clinical state prior to initiation of support was identified as scai shock stage d being supported by an iabp.The patient went to the icu on support with the 14 fr low profile sheath in place as instructed in the ifu.Post procedure it was noted that the impella insertion site was oozing.It is important to appreciate the risk of utilizing the same arteriotomy when exchanging the iabp for the impella.The physician voiced that they felt the initial stick for iabp was high which was contributing to the oozing.Standard troubleshooting and redressing the site resolved the ooze.After approximately 24 hours of support the patient was taken back to the cath lab for removal at which time the access site was flat and dry.Upon removal of the device there were noted concerns of thrombus but no documented thrombus related adverse event to the patient.In further discussions regarding the thrombosis there was information shared that the thrombus required multiple aspirations to remove the clot burden.By the 3rd aspiration the clot burden was remedied and the aspiration was clear.While on support the device functioned within expected flow range p-6 2.7l/min.Percutaneous coronary intervention.
|
| |
|
Search Alerts/Recalls
|